CryoPort (CYRX) Stock Price, News & Analysis

Company Overview

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.

Key Stats

• Today's Range: $7.25 to $7.55
• 50-Day Range: $5.40 to $7.46
• 52-Week Range: $4.58 to $9.77
• Volume: 353,794 shs
• Average Volume: 462,291 shs
• Market Capitalization: $373.79 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $11.00
• Consensus Rating: Moderate Buy

CryoPort Stock Analysis - MarketRank™

CryoPort scored higher than 47% of companies evaluated by MarketBeat, and ranked 77th out of 124 stocks in the transportation sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

CryoPort has received a consensus rating of Moderate Buy. The company's average rating score is 2.71, and is based on 5 buy ratings, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

CryoPort has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: Decreasing

Earnings Growth

Earnings for CryoPort are expected to decrease in the coming year, from ($0.99) to ($1.06) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of CryoPort is -3.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of CryoPort is -3.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

CryoPort has a P/B Ratio of 1.01. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.08% of the float of CryoPort has been sold short.

Short Interest Ratio / Days to Cover

CryoPort has a short interest ratio ("days to cover") of 4.8.

Change versus previous month

Short interest in CryoPort has recently decreased by 3.17%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

CryoPort does not currently pay a dividend.

Dividend Growth

CryoPort does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

5.08% of the float of CryoPort has been sold short.

Short Interest Ratio / Days to Cover

CryoPort has a short interest ratio ("days to cover") of 4.8.

Change versus previous month

Short interest in CryoPort has recently decreased by 3.17%, indicating that investor sentiment is improving.

News and Social Media

• Score: 2.0 / 5
• News Sentiment: 0.66

News Sentiment

CryoPort has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Transportation companies.

News Coverage This Week

MarketBeat has tracked 8 news articles for CryoPort this week, compared to 3 articles on an average week.

MarketBeat Follows

Only 1 people have added CryoPort to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, CryoPort insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,042,327.00 in company stock.

Percentage Held by Insiders

10.10% of the stock of CryoPort is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

92.90% of the stock of CryoPort is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

CYRX Stock Analysis - Frequently Asked Questions

How have CYRX shares performed this year?

CryoPort's stock was trading at $7.78 at the beginning of the year. Since then, CYRX shares have decreased by 3.1% and is now trading at $7.54.
View the best growth stocks for 2025 here.

How were CryoPort's earnings last quarter?

CryoPort, Inc. (NASDAQ:CYRX) released its earnings results on Wednesday, May, 7th. The company reported ($0.22) earnings per share for the quarter, beating the consensus estimate of ($0.23) by $0.01. The firm had revenue of $41.04 million for the quarter, compared to analysts' expectations of $56.19 million. CryoPort had a negative trailing twelve-month return on equity of 11.03% and a negative net margin of 50.15%.
Read the conference call transcript.

Is CryoPort doing a stock buyback?

CryoPort's board initiated a stock buyback program on Tuesday, August 6th 2024, which allows the company to repurchase $200,000,000 in shares, according to EventVestor. This means that the company could purchase up to 49.1% of its shares through open market purchases. Shares buyback programs are often a sign that the company's management believes its shares are undervalued.

How do I buy shares of CryoPort?

Shares of CYRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of CryoPort own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CryoPort investors own include American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AU Optronics (AUOTY), DiamondRock Hospitality (DRH) and Humana (HUM).

Company Calendar

• Last Earnings: 5/07/2025
• Today: 7/02/2025
• Next Earnings (Estimated): 8/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Transportation
• Industry: TRANS - SERVICES
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:CYRX
• CIK: 1124524
• Web: www.cryoport.com
• Phone: (949) 470-2300
• Fax: 949-470-2306
• Employees: 1,186
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $11.00
• High Stock Price Target: $15.00
• Low Stock Price Target: $7.00
• Potential Upside/Downside: +48.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.71
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): ($2.34)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$114.76 million
• Net Margins: -50.15%
• Pretax Margin: -49.97%
• Return on Equity: -11.03%
• Return on Assets: -5.54%

Debt

• Debt-to-Equity Ratio: 0.51
• Current Ratio: 5.56
• Quick Ratio: 5.24

Sales & Book Value

• Annual Sales: $228.38 million
• Price / Sales: 1.63
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $7.44 per share
• Price / Book: 1.00

Miscellaneous

• Outstanding Shares: 50,140,000
• Free Float: 45,073,000
• Market Cap: $371.79 million
• Optionable: Optionable
• Beta: 1.88